Zhenguo Liu, MD, Huiyu Feng, MD, Sai-Ching J

Slides:



Advertisements
Similar presentations
Photodynamic Laser Therapy for Lesions in the Airway
Advertisements

Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery  Michael E. Halkos, MD,
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,
Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.
Reply The Annals of Thoracic Surgery
Outcomes of Reintervention on the Autograft After Ross Procedure
Impact of Solid Minor Histologic Subtype in Postsurgical Prognosis of Stage I Lung Adenocarcinoma  Tianxiang Chen, MD, PhD, Jizhuang Luo, MD, Haiyong.
Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.
Minimally Invasive Versus Sternotomy Approach for Mitral Valve Surgery in Patients Greater Than 70 Years Old: A Propensity-Matched Comparison  David M.
Richard K. Freeman, MD, Anthony J. Ascioti, MD, Jaclyn M
Comparing Long-Term Survival Between Patients Undergoing Off-Pump and On-Pump Coronary Artery Bypass Graft Operations  Giovanni Filardo, PhD, MPH, Paul.
Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T
The Impact of Peripheral Vascular Disease on Long-Term Survival After Coronary Artery Bypass Graft Surgery  Danny Chu, MD, Faisal G. Bakaeen, MD, Xing.
Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery  Michael E. Halkos, MD,
Long-Term Survival After Arterial Versus Atrial Switch in d-Transposition of the Great Arteries  Alexander Kiener, MD, MPH, Michael Kelleman, MSPH, Courtney.
Castigliano M. Bhamidipati, DO, MS, George J
Prognostic Variables in Thoracic Esophageal Squamous Cell Carcinoma
Transcervical thymectomy for myasthenia gravis achieves results comparable to thymectomy by sternotomy  Joseph B Shrager, MD, Maher E Deeb, MD, Rosemarie.
Linda Henry, PhD, RN, Linda Halpin, MSN, RN, Sharon Hunt, MBA, Sari D
Anthony Lemaire, MD, William R
Total Arch Replacement With Stented Elephant Trunk Technique for Acute Type B Aortic Dissection Involving the Aortic Arch  Hai-Peng Zhao, MD, Jun-Ming.
Chris Dickhoff, MD, Max Dahele, MD, PhD, Sayed M
Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D
Readmission to Intensive Care Unit After Initial Recovery From Major Thoracic Oncology Surgery  Suk-Won Song, MD, Hyun-Sung Lee, MD, PhD, Jae-Hyun Kim,
Robotic Thymectomy in Anterior Mediastinal Mass: Propensity Score Matching Study With Transsternal Thymectomy  Chang Hyun Kang, MD, PhD, Yoohwa Hwang,
Chordae Replacement Versus Resection for Repair of Isolated Posterior Mitral Leaflet Prolapse: À Ègalité  Joerg Seeburger, MD, Volkmar Falk, MD, PhD,
Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery  James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,
Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R
Analyzing Effectiveness of Routine Pleural Drainage After Nuss Procedure: A Randomized Study  Krystian Pawlak, MD, PhD, Łukasz Gąsiorowski, MD, PhD, Piotr.
Who Do You Say You Are? The Annals of Thoracic Surgery
Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma  Shinsuke Sasada, MD, PhD, Yoshihiro Miyata, MD, PhD,
Karam Nam, MD, Yoon Sang Park, MD, Won Ho Kim, MD, PhD 
Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis  Shahid I. Sheikh, MD, Don Hayes,
Radical Lymph Node Dissection in Primary Esophagectomy for Esophageal Squamous Cell Carcinoma  Chen-Sung Lin, MD, PhD, Chih-Tao Cheng, MD, DrPH, Chao-Yu.
Seth D. Goldstein, MD, Stephen C. Yang, MD 
Use of Amiodarone After Major Lung Resection
Impact of Blood Product Transfusion on Short and Long-Term Survival After Cardiac Surgery: More Evidence  Balu Bhaskar, MD, FCICM, Joel Dulhunty, PhD,
Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer  Raymond U.
Mallory L. Irons, MD, MBE, J. William Gaynor, MD, Thomas L
Comparison of Conservative Treatment and Thymectomy on Myasthenia Gravis Outcome  Emanuela Taioli, MD, PhD, Philip Kent Paschal, Bian Liu, PhD, Andrew.
Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R
Matthew J. Bott, MD, Hanghang Wang, BA, William Travis, MD, Gregory J
Role of Surgical Ventricular Restoration in the Treatment of Ischemic Cardiomyopathy  Jun Liu, MD, Zixiong Liu, MD, Qiang Zhao, MD, Anqing Chen, MD, Zhe.
Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D
Surgical Repair for Acute Type A Aortic Dissection in Octogenarians
Extent of Lymphadenectomy Is Associated With Improved Overall Survival After Esophagectomy With or Without Induction Therapy  Pamela Samson, MD, MPHS,
Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer  Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.
Postoperative Extracorporeal Membrane Oxygenation Support for Acute Type A Aortic Dissection  Ting-Wei Lin, MD, MS, Meng-Ta Tsai, MD, Yu-Ning Hu, MD,
Characteristics of Malignant Pleural Mesothelioma in Women
Comparative Clinical Features and Immune Responses After Extended Thymectomy for Myasthenia Gravis in Patients With Atrophic Versus Hyperplastic Thymus 
A. Thomas Pezzella, MD, Sari D
Patrick O. Myers, MD  The Annals of Thoracic Surgery 
Serum Protein Profiles in Myasthenia Gravis
Joseph B. Shrager, MD  The Annals of Thoracic Surgery 
The Annals of Thoracic Surgery
Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population  Christian McNeely, MD, Stephen.
Prolonged Intensive Care Unit Stay in Cardiac Surgery: Risk Factors and Long-Term- Survival  Ortrud Vargas Hein, MD, Jürgen Birnbaum, MD, Klaus Wernecke,
Massimo Meco, MD, Silvia Cirri, MD  The Annals of Thoracic Surgery 
Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D
Early Prognosis of Reduction Ascending Aortoplasty in Patients With Aortic Valve Disease: A Single Center’s Experience  Shen Liu, MD, Yi Shi, MD, Ruofan.
Experience with programmed steroid treatment with thymectomy in nonthymomatous myasthenia gravis  Shunsuke Endo, MD, Tsutomu Yamaguchi, MD, Noriko Saito,
Self-Management of Oral Anticoagulation Therapy Improves Long-Term Survival in Patients With Mechanical Heart Valve Replacement  Heinrich Koertke, MD,
Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD 
Risk of Valve-Related Events After Aortic Valve Repair
Surgical Treatment for Multidrug-Resistant and Extensive Drug-Resistant Tuberculosis  Min-Woong Kang, MD, Hong Kwan Kim, MD, Yong Soo Choi, MD, Kwhanmien.
Detailed Analysis of Prognostic Factors in Primary Esophageal Small Cell Carcinoma  Wei-Wei Chen, MD, Feng Wang, MD, PhD, ShaoBin Chen, MD, Luhua Wang,
J. Alberto Lopez, MD  The Annals of Thoracic Surgery 
Presentation transcript:

Extended Transsternal Thymectomy for the Treatment of Ocular Myasthenia Gravis  Zhenguo Liu, MD, Huiyu Feng, MD, Sai-Ching J. Yeung, MD, PhD, Ziyu Zheng, MD, Weibin Liu, MD, Jun Ma, MD, Fo-tian Zhong, MD, Honghe Luo, MD, Chao Cheng, MD, PhD  The Annals of Thoracic Surgery  Volume 92, Issue 6, Pages 1993-1999 (December 2011) DOI: 10.1016/j.athoracsur.2011.08.001 Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Kaplan-Meier curves of patients who experienced complete remission (CR) of ocular myasthenia gravis (OMG) after undergoing extended transsternal thymectomy (ETT). The CR was defined using the standard of strict complete remission (SCR) (A, C) and the broader standard of general complete remission (GCR), which included asymptomatic patients receiving low-dose single-drug immunosuppressive therapy (B, D). Patients on whom analysis was done for probability of SCR versus time after surgery (C) and probability of GCR versus time after surgery (D) were grouped according to duration of symptoms, with those whose symptoms had lasted 12 months or less showing greater improvement after ETT in terms of both SCR and GCR. The numbers below the figures denote the number of patients at risk in each group. Values of p < 0.05 were considered significant. (CI = confidence interval; HR = hazard ratio.) The Annals of Thoracic Surgery 2011 92, 1993-1999DOI: (10.1016/j.athoracsur.2011.08.001) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions